Literature DB >> 200907

Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.

W E Stewart, L S Lin, M Wiranowska-Stewart, K Cantell.   

Abstract

Human leukocyte interferon (HuLeIF) preparations contain distinct molecular forms of interferon exhibiting significant heterogeneties in sizes when analyzed by electrophoresis in sodium dodecyl sulfate (NaDodSO(4))/polyacrylamide gels, migrating in two broad bands of activity with peaks at about 21,000 and 15,000 daltons. HuLeIFs exhibit extensive charge heterogeneities when analyzed by isoelectric focusing, resolving into several major peaks of approximately equal activity distributed from pH 5.7 to 7.0. When HuLeIF preparations are treated with 0.01 M sodium periodate buffer, pH 4.5, at 4 degrees , both the size and charge heterogeneities rapidly disappear: periodate-treated HuLeIF migrates as a single, narrow band at 15,000 daltons in NaDodSO(4)/polyacrylamide gels and focuses as a single, narrow band at pH 5.7. Quantitative considerations suggest that either the larger, heterogeneously charged HuLeIFs are converted to the smaller, size- and charge-homogeneous interferon by extensive chemical deglycosylation, or, alternatively, the smaller, 15,000 dalton, pH 5.7 interferon is much more stable to periodate treatment than are the other interferon forms. However, the activity of each of the variously charged forms of HuLeIF isolated from focusing gels exhibited the same stability as the pH 5.7 component; similarly, the activity of each of the size-forms of HuLeIF isolated from NaDodSO(4)/polyacrylamide gels exhibited the same stability as the 15,000-dalton interferon.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200907      PMCID: PMC431906          DOI: 10.1073/pnas.74.10.4200

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Purification of interferon by adsorption chromatography on controlled pore glass.

Authors:  V G Edy; I A Braude; E De Clercq; A Billiau; P De Somer
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

2.  Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation.

Authors:  E A Havell; S Yamazaki; J Vilcek
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

3.  Distinct molecular species of interferons.

Authors:  W E Stewart
Journal:  Virology       Date:  1974-09       Impact factor: 3.616

4.  No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.

Authors:  K E Mogensen; L Pyhälä; E Törmä; K Cantell
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

5.  Pronounced antiviral activity of human interferon on bovine and porcine cells.

Authors:  I Gresser; M T Bandu; D Brouty-boye; M Tovey
Journal:  Nature       Date:  1974-10-11       Impact factor: 49.962

6.  De novo cell-free synthesis of human interferon.

Authors:  S Pestka; J McInnes; D Weiss; E A Havell; J Vilcek
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

7.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

8.  Biological properties of human leukocyte interferon components.

Authors:  K Paucker; B J Dalton; E T Törmä; C A Ogburn
Journal:  J Gen Virol       Date:  1977-05       Impact factor: 3.891

9.  Relationship between the physicochemical nature of human interferon, the cell induced, and the inducing agent.

Authors:  T C Cesario; P J Schryer; J G Tilles
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  13 in total

1.  Hepatitis B virus suppresses expression of human beta-interferon.

Authors:  J S Twu; C H Lee; P M Lin; R H Schloemer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

2.  Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms.

Authors:  W E Stewart; T Chudzio; L S Lin; M Wiranowska-Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters.

Authors:  Irene Lo Cigno; Marco De Andrea; Cinzia Borgogna; Silvia Albertini; Manuela M Landini; Alberto Peretti; Karen E Johnson; Bala Chandran; Santo Landolfo; Marisa Gariglio
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

4.  Glycosylation of human leukocyte interferon: effects of tunicamycin.

Authors:  K C Chadha; P M Grob; R L Hamill; E Sulkowski
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

5.  Spontaneous production of human interferon.

Authors:  L A Pickering; L H Kronenberg; W E Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

6.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 7.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  Size characteristics of human leucocyte interferon under reducing and non-reducing conditions.

Authors:  I A Braude; L S Lin; W E Stewart
Journal:  Biochem J       Date:  1981-03-01       Impact factor: 3.857

9.  Human leukocyte interferon: separation of biologically different species by modification of carbohydrate moieties.

Authors:  M G Salit; C A Ogburn
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

10.  Human leukocyte interferon: relationship between molecular structure and species specificity.

Authors:  M N Thang; D C Thang; M K Chelbi-Alix; B Robert-Galliot; M J Commoy-Chevalier; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.